This study used the Proportion of Days Covered (PDC) because it is more sensitive to capturing uncovered days compared to the Medication Possession Ratio
Methods: We retrieved reports of AEs associated with treatment with GLP-1 RAs during the period from the first quarter (Q1) of 2004 to Q1 2023 from the FDA Adverse Event Reporting System (FAERS) database
And every pharma company that missed out on this early wave is doubling down on their research pipeline and manufacturing capacity
Non-oral methods, such as IUDs, implants, the patch, the ring, and the shot, are the most reliable choices because theyre not affected by changes in digestion or absorption
Clinically proven approach Doctor prescribed & medically supervised Personalized dosing for optimal results Ongoing support from our care team *These statements have not been evaluated by the Food and Drug Administration
For a detailed overview of brain repair peptides , the dedicated guide provides broader context